Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hypogonadism × Anastrozole × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Endocrine 1

Conditions

Obesity 2 Breast Neoplasms 2 Vitamin D Deficiency 1 Sexual Dysfunction, Physiological 1 Seizures 1 Nutrition Disorders 1 Multiple Endocrine Neoplasia Type 1 1 Hypogonadism 1 Erectile Dysfunction 1 Epilepsy 1 Arthralgia 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00179517 2019-07-17

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

Beth Israel Deaconess Medical Center

Phase 2 Completed

40 enrolled 13 charts

Epilepsy, Hypogonadism, Erectile Dysfunction, Seizures, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡